Abstract
An innovative gene therapy approach to produce novel GALC variant with enhanced protein stability and enzyme activity with high levels of mannose 6-phosphate for Krabbe disease
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have